588 89

Cited 0 times in

Antihypertensive Medication Adherence and Cardiovascular Outcomes in Patients With Cancer: A Nationwide Population-Based Cohort Study

Authors
 Mi-Hyang Jung  ;  So-Young Lee  ;  Jong-Chan Youn  ;  Woo-Baek Chung  ;  Sang-Hyun Ihm  ;  Dongwoo Kang  ;  Dae-Sung Kyoung  ;  Hae Ok Jung  ;  Kiyuk Chang  ;  Ho-Joong Youn  ;  Hokyou Lee  ;  Danbee Kang  ;  Juhee Cho  ;  Hidehiro Kaneko  ;  Hyeon Chang Kim 
Citation
 JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.12(14) : e029362, 2023-07 
Journal Title
JOURNAL OF THE AMERICAN HEART ASSOCIATION
Issue Date
2023-07
MeSH
Adult ; Antihypertensive Agents / therapeutic use ; Cardiovascular Diseases* / drug therapy ; Cardiovascular Diseases* / epidemiology ; Cardiovascular Diseases* / prevention & control ; Cohort Studies ; Humans ; Hypertension* / drug therapy ; Hypertension* / epidemiology ; Medication Adherence ; Neoplasms* / complications ; Neoplasms* / drug therapy ; Neoplasms* / epidemiology
Keywords
adherence ; cancer ; cardiovascular disease ; hypertension ; survivorship
Abstract
Background Hypertension is an important cause of morbidity, which predisposes patients to major cardiovascular events and mortality. The aim of this study was to explore the association between adherence to antihypertensive medication and clinical outcomes in adult patients with cancer. Methods and Results Using the 2002 to 2013 Korean National Health Insurance Service-National Sample Cohort, we extracted adult patients with cancer treated with antihypertensive medications. Based on the medication possession ratio value, participants were divided into 3 groups: good (medication possession ratio ≥0.8), moderate (0.5≤ medication possession ratio <0.8), and poor (medication possession ratio <0.5) adherence groups. The primary outcomes were overall and cardiovascular mortality. The secondary outcome was cardiovascular events requiring hospitalization due to major cardiovascular diseases. Among 19 246 patients with cancer with concomitant hypertension, 66.4% were in the nonadherence group (26.3% were moderate and 40.0% were poor adherence group). Over a median of 8.4 years of follow-up, 2752 deaths and 6057 cardiovascular events occurred. Compared with the good adherence group, the moderate and poor adherence groups had a 1.85-fold and 2.19-fold increased risk for overall mortality, and 1.72-fold and 1.71-fold elevated risk for cardiovascular mortality, respectively, after adjustment for possible confounders. Furthermore, the moderate and poor adherence groups had a 1.33-fold and 1.34-fold elevated risk of new-onset cardiovascular events, respectively. These trends were consistent across cardiovascular event subtypes. Conclusions Nonadherence to antihypertensive medication was common in patients with cancer and was associated with worse clinical outcomes in adult patients with cancer with hypertension. More attention should be paid to improving adherence to antihypertensive medication among patients with cancer.
Files in This Item:
T202400270.pdf Download
DOI
10.1161/JAHA.123.029362
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers
Yonsei Authors
Kim, Hyeon Chang(김현창) ORCID logo https://orcid.org/0000-0001-7867-1240
Lee, Hokyou(이호규) ORCID logo https://orcid.org/0000-0002-5034-8422
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/197852
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links